Antimicrobial Susceptibility Testing Market Insights, Competitive Landscape, and Market Forecast

Description

The global Antimicrobial Susceptibility Testing (AST) Market is set to witness strong growth, with a projected market size of USD 6.6 billion in 2026, reaching USD 10.46 billion by 2033 at a CAGR of 6.8%. AST plays a critical role in identifying the susceptibility of microorganisms to antibiotics and antifungal agents, guiding clinicians in selecting effective treatments. As antimicrobial resistance continues to rise globally, AST has become an essential tool in healthcare, ensuring precise therapies and minimizing the spread of drug-resistant infections.

Market Insights

The AST market is expanding rapidly due to technological advancements and increased adoption of automated testing solutions. Methods such as E-TEST, disk diffusion, and rapid automated techniques have improved accuracy and reduced turnaround time, enabling faster clinical decision-making. Heightened awareness of antimicrobial resistance, coupled with regulatory mandates for standardized testing, is further driving market demand. The need for timely and reliable diagnostics in hospitals, laboratories, and research institutions continues to boost the adoption of AST solutions worldwide.

Drivers

Key factors fueling the market growth include:

The rising prevalence of antibiotic-resistant infections, emphasizing the need for precise and rapid testing methods.
Expansion of healthcare infrastructure, including hospitals and clinical laboratories, which increases demand for advanced diagnostic tools.
Growing R&D efforts by pharmaceutical and biotechnology companies to develop novel antibiotics and antifungal drugs.
Increased focus on antimicrobial stewardship programs to combat drug resistance.
Lessons learned from the COVID-19 pandemic, highlighting the importance of rapid pathogen detection and microbial diagnostics.

Business Opportunities

The AST market offers significant opportunities for innovation and expansion:

Development of rapid, automated, and multiplex testing platforms.
Strategic partnerships with healthcare institutions and governmental agencies to expand laboratory testing capacity.
Introduction of cost-effective AST solutions for emerging economies facing a high burden of infectious diseases.
Enhancing diagnostic accuracy through integration with artificial intelligence and data analytics.

Regional Analysis

North America: Dominates the market due to advanced healthcare infrastructure, widespread adoption of diagnostic technologies, and strong R&D investment.
Europe: Exhibits steady growth, driven by regulatory frameworks and antimicrobial stewardship initiatives.
Asia Pacific: A fast-growing market fueled by increasing infectious disease prevalence, expanding healthcare facilities, and rising awareness about antimicrobial resistance.
Latin America & Middle East & Africa: Emerging markets showing significant potential due to ongoing healthcare modernization and investments in laboratory diagnostics.

Key Players

Thermo Fisher Scientific Inc.
bioMerieux S.A.
Becton, Dickinson and Company (BD)
Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
Siemens Healthineers AG
Beckman Coulter (Danaher Corporation)
bioLoomics, Inc.
Liofilchem Srl
Bruker Corporation
Oxoid (part of Thermo Fisher Scientific)
Thermo Scientific - TREK Diagnostic Systems
Trek Diagnostic Systems (Thermo Fisher brand)
Hardy Diagnostics
ELITechGroup
Mast Group Ltd.

Market Segmentation

By Test Type

Antibacterial Testing
Antifungal Testing
Others

By Method

E-TEST
Disks Diffusion
Rapid Automation Method
Others

By Application

Diagnostics
Drug Discovery & Development
Others

By End-Users

Hospitals & Clinics
Clinical Laboratories
Pharmaceutical & Biotechnology Companies
Others

By Geography

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

1. Executive Summary

1.1. Global Antimicrobial Susceptibility Testing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Fiver Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors

3. Global Antimicrobial Susceptibility Testing Market Outlook, 2020-2033

3.1. Global Antimicrobial Susceptibility Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
- 3.1.1. Antibacterial Testing
- 3.1.2. Antifungal Testing
- 3.1.3. Others
3.2. Global Antimicrobial Susceptibility Testing Market Outlook, by Method, Value (US$ Bn), 2020-2033
- 3.2.1. E-TEST
- 3.2.2. Disks Diffusion
- 3.2.3. Rapid Automation Method
- 3.2.4. Others
3.3. Global Antimicrobial Susceptibility Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 3.3.1. Diagnostics
- 3.3.2. Drug Discovery & Development
- 3.3.3. Others
3.4. Global Antimicrobial Susceptibility Testing Market Outlook, by End-Users, Value (US$ Bn), 2020-2033
- 3.4.1. Hospitals & Clinics
- 3.4.2. Clinical Laboratories
- 3.4.3. Pharmaceutical & Biotechnology Companies
- 3.4.4. Others
3.5. Global Antimicrobial Susceptibility Testing Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.5.1. North America
- 3.5.2. Europe
- 3.5.3. Asia Pacific
- 3.5.4. Latin America
- 3.5.5. Middle East & Africa

4. North America Antimicrobial Susceptibility Testing Market Outlook, 2020-2033

4.1. North America Antimicrobial Susceptibility Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
- 4.1.1. Antibacterial Testing
- 4.1.2. Antifungal Testing
- 4.1.3. Others
4.2. North America Antimicrobial Susceptibility Testing Market Outlook, by Method, Value (US$ Bn), 2020-2033
- 4.2.1. E-TEST
- 4.2.2. Disks Diffusion
- 4.2.3. Rapid Automation Method
- 4.2.4. Others
4.3. North America Antimicrobial Susceptibility Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 4.3.1. Diagnostics
- 4.3.2. Drug Discovery & Development
- 4.3.3. Others
4.4. North America Antimicrobial Susceptibility Testing Market Outlook, by End-Users, Value (US$ Bn), 2020-2033
- 4.4.1. Hospitals & Clinics
- 4.4.2. Clinical Laboratories
- 4.4.3. Pharmaceutical & Biotechnology Companies
- 4.4.4. Others
4.5. North America Antimicrobial Susceptibility Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.5.1. U.S. Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 4.5.2. U.S. Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 4.5.3. U.S. Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 4.5.4. U.S. Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 4.5.5. Canada Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 4.5.6. Canada Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 4.5.7. Canada Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 4.5.8. Canada Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
4.6. BPS Analysis/Market Attractiveness Analysis

5. Europe Antimicrobial Susceptibility Testing Market Outlook, 2020-2033

5.1. Europe Antimicrobial Susceptibility Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
- 5.1.1. Antibacterial Testing
- 5.1.2. Antifungal Testing
- 5.1.3. Others
5.2. Europe Antimicrobial Susceptibility Testing Market Outlook, by Method, Value (US$ Bn), 2020-2033
- 5.2.1. E-TEST
- 5.2.2. Disks Diffusion
- 5.2.3. Rapid Automation Method
- 5.2.4. Others
5.3. Europe Antimicrobial Susceptibility Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 5.3.1. Diagnostics
- 5.3.2. Drug Discovery & Development
- 5.3.3. Others
5.4. Europe Antimicrobial Susceptibility Testing Market Outlook, by End-Users, Value (US$ Bn), 2020-2033
- 5.4.1. Hospitals & Clinics
- 5.4.2. Clinical Laboratories
- 5.4.3. Pharmaceutical & Biotechnology Companies
- 5.4.4. Others
5.5. Europe Antimicrobial Susceptibility Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.5.1. Germany Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 5.5.2. Germany Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 5.5.3. Germany Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 5.5.4. Germany Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 5.5.5. Italy Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 5.5.6. Italy Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 5.5.7. Italy Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 5.5.8. Italy Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 5.5.9. France Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 5.5.10. France Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 5.5.11. France Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 5.5.12. France Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 5.5.13. U.K. Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 5.5.14. U.K. Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 5.5.15. U.K. Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 5.5.16. U.K. Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 5.5.17. Spain Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 5.5.18. Spain Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 5.5.19. Spain Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 5.5.20. Spain Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 5.5.21. Russia Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 5.5.22. Russia Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 5.5.23. Russia Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 5.5.24. Russia Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 5.5.25. Rest of Europe Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 5.5.26. Rest of Europe Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 5.5.27. Rest of Europe Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 5.5.28. Rest of Europe Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
5.6. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Antimicrobial Susceptibility Testing Market Outlook, 2020-2033

6.1. Asia Pacific Antimicrobial Susceptibility Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
- 6.1.1. Antibacterial Testing
- 6.1.2. Antifungal Testing
- 6.1.3. Others
6.2. Asia Pacific Antimicrobial Susceptibility Testing Market Outlook, by Method, Value (US$ Bn), 2020-2033
- 6.2.1. E-TEST
- 6.2.2. Disks Diffusion
- 6.2.3. Rapid Automation Method
- 6.2.4. Others
6.3. Asia Pacific Antimicrobial Susceptibility Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 6.3.1. Diagnostics
- 6.3.2. Drug Discovery & Development
- 6.3.3. Others
6.4. Asia Pacific Antimicrobial Susceptibility Testing Market Outlook, by End-Users, Value (US$ Bn), 2020-2033
- 6.4.1. Hospitals & Clinics
- 6.4.2. Clinical Laboratories
- 6.4.3. Pharmaceutical & Biotechnology Companies
- 6.4.4. Others
6.5. Asia Pacific Antimicrobial Susceptibility Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.5.1. China Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 6.5.2. China Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 6.5.3. China Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 6.5.4. China Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 6.5.5. Japan Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 6.5.6. Japan Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 6.5.7. Japan Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 6.5.8. Japan Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 6.5.9. South Korea Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 6.5.10. South Korea Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 6.5.11. South Korea Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 6.5.12. South Korea Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 6.5.13. India Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 6.5.14. India Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 6.5.15. India Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 6.5.16. India Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 6.5.17. Southeast Asia Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 6.5.18. Southeast Asia Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 6.5.19. Southeast Asia Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 6.5.20. Southeast Asia Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 6.5.21. Rest of SAO Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 6.5.22. Rest of SAO Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 6.5.23. Rest of SAO Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 6.5.24. Rest of SAO Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
6.6. BPS Analysis/Market Attractiveness Analysis

7. Latin America Antimicrobial Susceptibility Testing Market Outlook, 2020-2033

7.1. Latin America Antimicrobial Susceptibility Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
- 7.1.1. Antibacterial Testing
- 7.1.2. Antifungal Testing
- 7.1.3. Others
7.2. Latin America Antimicrobial Susceptibility Testing Market Outlook, by Method, Value (US$ Bn), 2020-2033
- 7.2.1. E-TEST
- 7.2.2. Disks Diffusion
- 7.2.3. Rapid Automation Method
- 7.2.4. Others
7.3. Latin America Antimicrobial Susceptibility Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 7.3.1. Diagnostics
- 7.3.2. Drug Discovery & Development
- 7.3.3. Others
7.4. Latin America Antimicrobial Susceptibility Testing Market Outlook, by End-Users, Value (US$ Bn), 2020-2033
- 7.4.1. Hospitals & Clinics
- 7.4.2. Clinical Laboratories
- 7.4.3. Pharmaceutical & Biotechnology Companies
- 7.4.4. Others
7.5. Latin America Antimicrobial Susceptibility Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.5.1. Brazil Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 7.5.2. Brazil Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 7.5.3. Brazil Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 7.5.4. Brazil Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 7.5.5. Mexico Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 7.5.6. Mexico Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 7.5.7. Mexico Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 7.5.8. Mexico Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 7.5.9. Argentina Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 7.5.10. Argentina Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 7.5.11. Argentina Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 7.5.12. Argentina Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 7.5.13. Rest of LATAM Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 7.5.14. Rest of LATAM Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 7.5.15. Rest of LATAM Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 7.5.16. Rest of LATAM Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
7.6. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Antimicrobial Susceptibility Testing Market Outlook, 2020-2033

8.1. Middle East & Africa Antimicrobial Susceptibility Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
- 8.1.1. Antibacterial Testing
- 8.1.2. Antifungal Testing
- 8.1.3. Others
8.2. Middle East & Africa Antimicrobial Susceptibility Testing Market Outlook, by Method, Value (US$ Bn), 2020-2033
- 8.2.1. E-TEST
- 8.2.2. Disks Diffusion
- 8.2.3. Rapid Automation Method
- 8.2.4. Others
8.3. Middle East & Africa Antimicrobial Susceptibility Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 8.3.1. Diagnostics
- 8.3.2. Drug Discovery & Development
- 8.3.3. Others
8.4. Middle East & Africa Antimicrobial Susceptibility Testing Market Outlook, by End-Users, Value (US$ Bn), 2020-2033
- 8.4.1. Hospitals & Clinics
- 8.4.2. Clinical Laboratories
- 8.4.3. Pharmaceutical & Biotechnology Companies
- 8.4.4. Others
8.5. Middle East & Africa Antimicrobial Susceptibility Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.5.1. GCC Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 8.5.2. GCC Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 8.5.3. GCC Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 8.5.4. GCC Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 8.5.5. South Africa Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 8.5.6. South Africa Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 8.5.7. South Africa Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 8.5.8. South Africa Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 8.5.9. Egypt Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 8.5.10. Egypt Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 8.5.11. Egypt Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 8.5.12. Egypt Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 8.5.13. Nigeria Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 8.5.14. Nigeria Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 8.5.15. Nigeria Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 8.5.16. Nigeria Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
- 8.5.17. Rest of Middle East Antimicrobial Susceptibility Testing Market Outlook, by Test Type, 2020-2033
- 8.5.18. Rest of Middle East Antimicrobial Susceptibility Testing Market Outlook, by Method, 2020-2033
- 8.5.19. Rest of Middle East Antimicrobial Susceptibility Testing Market Outlook, by Application, 2020-2033
- 8.5.20. Rest of Middle East Antimicrobial Susceptibility Testing Market Outlook, by End-Users, 2020-2033
8.6. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Thermo Fisher Scientific Inc.
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Developments
- 9.4.2. bioMerieux S.A.
- 9.4.3. Becton, Dickinson and Company (BD)
- 9.4.4. Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
- 9.4.5. Siemens Healthineers AG
- 9.4.6. Beckman Coulter (Danaher Corporation)
- 9.4.7. bioLoomics, Inc.
- 9.4.8. Liofilchem Srl
- 9.4.9. Bruker Corporation
- 9.4.10. Oxoid (part of Thermo Fisher Scientific)

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Antimicrobial Susceptibility Testing Market Insights, Competitive Landscape, and Market Forecast - 2033